Urological Research

, Volume 34, Issue 6, pp 351–357 | Cite as

Effect of extract of Phyllanthus niruri on crystal deposition in experimental urolithiasis

  • Marcio E. Barros
  • Roberta Lima
  • Lucildes P. Mercuri
  • Jivaldo R. Matos
  • Nestor Schor
  • Mirian A. Boim
Original Paper

Abstract

Phyllanthus niruri (Pn) is a plant that has been shown to interfere in the growth and aggregation of calcium oxalate (CaOx) crystals. In the present study we evaluated the effect of Pn on the preformed calculus induced by introduction of a CaOx seed into the bladder of male Wistar rats. Pn treatment (5 mg/rat/day) was initiated immediately or 30 days after CaOx seeding and thus in the presence of a preformed calculus. Animals were sacrificed 50 or 70 days after surgery. The resulting calculi were weighed and analyzed by X-ray diffraction, stereomicroscopy and scanning electronic microscopy. Precocious Pn treatment reduced the number (75%, P < 0.05) and the weight (65%, P < 0.05) of calculi that frequently exhibited a matrix-like material on its surface, compared to the untreated CaOx group. In contrast, Pn treatment in the presence of a preformed calculus did not prevent further calculus growth; rather, it caused an impressive modification in its appearance and texture. Calculi from Pn-treated animals had a smoother, homogeneous surface compared to the spicule shape of calculi found in the untreated CaOx group. XRD analysis revealed the precipitation of struvite crystals over the CaOx seed and Pn did not change the crystalline composition of the calculi. This suggests that Pn interfered with the arrangement of the precipitating crystals, probably by modifying the crystal–crystal and/or crystal–matrix interactions. Results suggest that Pn may have a therapeutic potential, since it was able to modify the shape and texture of calculi to a smoother and probably more fragile form, which could contribute to elimination and/or dissolution of calculi.

Keywords

Phyllanthus niruri Calcium oxalate Struvite Urolithiasis Rats 

References

  1. 1.
    Atmani F, Slimani Y, Mimouni M, Hacht B (2003) Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. BJU Int 92(1):137–140PubMedCrossRefGoogle Scholar
  2. 2.
    Rates SM (2001) Plants as source of drugs. Toxicon 39(5):603–613PubMedCrossRefGoogle Scholar
  3. 3.
    Mello JF (1980) Plants in traditional medicine in Brazil. J Ethnopharmacol 2(1):49–55PubMedCrossRefGoogle Scholar
  4. 4.
    Paulino N, Cechinel-Filho V, Yunes RA, Calixto JB (1996) The relaxant effect of extract of Phyllanthus urinaria in the guinea-pig isolated trachea. Evidence for involvement of ATP-sensitive potassium channels. J Pharm Pharmacol 48(11):1158–1163PubMedGoogle Scholar
  5. 5.
    Nishiura JL, Campos AH, Boim MA, Heilberg IP, Schor N (2004) Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urol Res 32(5):362–366PubMedCrossRefGoogle Scholar
  6. 6.
    Campos AH, Schor N (1999) Phyllanthus niruri inhibits calcium oxalate endocytosis by renal tubular cells: its role in urolithiasis. Nephron 81(4):393–397PubMedCrossRefGoogle Scholar
  7. 7.
    Freitas AM, Schor N, Boim MA (2002) The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. BJU Int 89(9):829–834PubMedCrossRefGoogle Scholar
  8. 8.
    Barros ME, Schor N, Boim MA (2003) Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro. Urol Res 30(6):374–397PubMedGoogle Scholar
  9. 9.
    Vermeulen CW, Grove WJ, Goetz R, Ragins HD, Correll NO (1950) Experimental urolithiasis. I. Development of calculi upon foreign bodies surgically introduced into bladders of rats. J Urol 64(4):541–548PubMedGoogle Scholar
  10. 10.
    Meyer JL, Smith LH (1975) Growth of calcium oxalate crystals. I. A model for urinary stone growth. Invest Urol 13(1):31–35PubMedCrossRefGoogle Scholar
  11. 11.
    Khan SR, Hackett RL (1987) Urolithogenesis of mixed foreign body stones. J Urol 138(5):1321–1328PubMedGoogle Scholar
  12. 12.
    Mann S. (1989) Biomineralization: chemical and biological perspectives. In: Mann S, Webb JM, Williams RJP (eds) Biomineralization: chemical and biological perspectives, Springer, Berlin Heidelberg New York, p 35Google Scholar
  13. 13.
    Hess B, Kok DJ. (1996) Kidney stones: medical and surgical stones. In: Preminger GM (ed) Kidney stones: medical and surgical stones, Lippencott-Raven, Philadelphia, p 3Google Scholar
  14. 14.
    Addadi L, Weiner S, Geva M (2001) On how proteins interact with crystals and their effect on crystal formation. Z Kardiol 90(Suppl 3):92–98PubMedGoogle Scholar
  15. 15.
    Heuer AH, Fink DJ, Laraia VJ et al (1992) Innovative materials processing strategies: a biomimetic approach. Science 255(5048):1098–1105PubMedCrossRefGoogle Scholar
  16. 16.
    Ryall RL (2000) The mystery of macromolecules: modulators, matrix and mineralization. Proceedings of the ninth international symposium on urolithiasis, pp 99–105Google Scholar
  17. 17.
    Kurutz JW, Carvalho C, Nakagawa Y (2003) Nephrocalcin isoforms coats surfaces and differentially affect calcium oxalate monohydrate crystal morphology, growth, and aggregation. J Cryst Growth 255:392–402CrossRefGoogle Scholar
  18. 18.
    Calixto JB, Santos AR, Cechinel Filho V, Yunes RA (1998) A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential. Med Res Rev 18(4):225–258PubMedCrossRefGoogle Scholar
  19. 19.
    Malini MM, Lenin M, Varalakshmi P (2000) Protective effect of triterpenes on calcium oxalate crystal-induced peroxidative changes in experimental urolithiasis. Pharmacol Res 41(4):413–418PubMedCrossRefGoogle Scholar
  20. 20.
    Vidya L, Lenin M, Varalakshmi P (2002) Evaluation of the effect of triterpenes on urinary risk factors of stone formation in pyridoxine deficient hyperoxaluric rats. Phytother Res 16(6):514–518PubMedCrossRefGoogle Scholar
  21. 21.
    Vidya L, Varalakshmi P (2000) Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria. Fitoterapia 71(5):535–543PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Marcio E. Barros
    • 1
  • Roberta Lima
    • 1
  • Lucildes P. Mercuri
    • 2
  • Jivaldo R. Matos
    • 2
  • Nestor Schor
    • 1
  • Mirian A. Boim
    • 1
    • 3
  1. 1.Department of Medicine, Renal DivisionFederal University of São PauloSão PauloBrazil
  2. 2.Chemistry InstituteUniversity of São PauloSão PauloBrazil
  3. 3.Disciplina de NefrologiaUNIFESPSão PauloBrazil

Personalised recommendations